2023 International Top-Down Proteomics Symposium
World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Symposium
20 sept. 2023 11h11 HE | Consortium for Top-Down Proteomics
Building the bridge from genotype to phenotype, the Symposium will feature scientific leaders creating cutting edge technologies and approaches that are ushering in the era of proteoform systems...
2023 International Top-Down Proteomics Symposium Image LG.jpg
The Consortium for Top-Down Proteomics Announces the 2nd International Top-Down Proteomics Symposium, October 3-5, 2023, in Chicago, IL
01 mars 2023 10h17 HE | Consortium for Top-Down Proteomics
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- The Consortium for Top-Down Proteomics today announced the 2nd International Top-Down Proteomics Symposium, which will be held in Chicago, IL...
IonSense logo lg (1).jpg
U.S. Customs and Border Protection Acquires Five IonSense® DART®-MS Systems
27 janv. 2020 10h00 HE | IonSense
SAUGUS, Mass., Jan. 27, 2020 (GLOBE NEWSWIRE) -- IonSense, Inc. has announced that the U.S. Customs and Border Protection Agency (CBP) has purchased five mass spectrometer systems equipped with...
20170406 Telix Logo.png
Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing
17 juin 2018 20h06 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 18, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
赛默飞与西比曼
西比曼与赛默飞达成战略合作   携手推进细胞治疗创新应用
06 nov. 2017 07h20 HE | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- 国内领先细胞治疗生物科技公司西比曼生物科技集团(Cellular Biomedicine Group,...
CBMG ThermoFisher signing
Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes
06 nov. 2017 07h20 HE | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm...